The U.S. Department of Health and Human Services Office of Inspector General said yesterday it has no comment on the status of referrals from the U.S. Health Resources and Services Administration to fine eight drug manufacturers for failing to offer
…
The New York legislature on Monday passed a short-term state funding bill with $9 million in supplemental aid for Ryan White clinics that are losing 340B revenue due to the April 1 transfer of the state’s Medicaid managed care drug
…
New Mexico Gov. Michelle Lujan Grisham (D) signed a law April 7 to prevent pharmacy benefit managers and insurers from discriminating against 340B providers. The bill includes language that prohibits payers from reimbursing 340B covered entities at a lower rate
…
A California state appeals court has affirmed a lower state court’s judgement that a 340B contract pharmacy overcharged the state Medicaid agency, Medi-Cal, nearly $2.5 million more than the pharmacy was entitled to receive for 340B drugs between May 2015
…
SPONSORED CONTENT
TIP: When using outsourced telehealth services, be prepared to “Mind the Gap.”
Telehealth services are a great
The state of Arkansas and Arkansas 340B covered entities separately asked a federal appeals court yesterday to back a judge’s decision in December that the state’s novel 340B anti-discrimination law is not preempted by the 340B statute nor by the
…
The American Hospital Association has again blasted the drug industry’s alliance with community health centers for 340B reform, calling it “another misguided attempt by drug companies to dismantle [340B] so that they can continue to pad their billion-dollar bottom lines.”
…
SPONSORED CONTENT
Leaders of hospitals, health centers and other 340B provider institutions are busy and don’t have time in their demanding days to be involved in the detailed, day-to-day financial oversight of their 340B programs. Yet, they also can’t afford to leave
…
U.S. Senate Health, Education, Labor, and Pensions Committee staff members reportedly have decided to exclude 340B issues from a bipartisan drug policy bill they are writing behind the scenes in order to preserve the bill’s odds of being passed next
…*Sign up for news summaries and alerts from 340B Report
